Le Lézard
Classified in: Health, Science and technology

Global Biocatalysis & Biocatalyst Market Report 2021 - ResearchAndMarkets.com

The "Biocatalysis & Biocatalyst Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

The biocatalysis & biocatalysts market is expected to grow with a CAGR of 15% from 2019 to 2024.

The future of the biocatalysis & biocatalysts market looks promising with opportunities in the food & beverages, cleaning agents, biofuel production, agriculture & feed, and biopharmaceuticals industries. The major growth drivers for this market are increasing penetration of biocatalysis in various industries, the increasing awareness about environment friendly products, and advancements in biocatalysis technology.

The study includes the biocatalysis & biocatalysts market size and forecast for the biocatalysis & biocatalysts market through 2024, segmented by end use industry, catalyst type, and region.

Some of the Biocatalysis & Biocatalysts companies profiled in this report include DowDuPont, Royal DSM N.V., Codexis Inc., BASF SE, AB Enzymes Gmbh, Amano Enzymes, Novozymes A/S, Chr. Hansen, Dyadic International Inc., and The Soufflet Group, and others.

Some of the features of Biocatalysis & Biocatalysts Market 2019-2024: Trends, Forecast, and Opportunity Analysis include:

This report answers the following 11 key questions:

Key Topics Covered:

1. Executive Summary

2. Industry Background and Classifications

2.1: Introduction, Background, and Classification

2.2: Supply Chain

2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024

3.1: Macroeconomic Trends and Forecast

3.2: Global Biocatalysis & Biocatalysts Market: Trends and Forecast

3.3: Global Biocatalysis & Biocatalysts Market by Catalyst Type:

3.3.1: Hydrolases

3.3.2: Oxidoreductases

3.3.3: Transferases

3.3.4: Others

3.4: Global Biocatalysis & Biocatalysts Market by End Use Industry:

3.4.1: Food & Beverages

3.4.2: Cleaning Agents

3.4.3: Biofuel Production

3.4.4: Agriculture & Feed

3.4.5: Biopharmaceuticals

3.4.6: Others

4. Market Trends and Forecast Analysis by Region

4.1: Global Biocatalysis & Biocatalysts Market by Region

5. Competitor Analysis

5.1: Product Portfolio Analysis

5.2: Market Share Analysis

5.3: Operational Integration

5.4: Geographical Reach

5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis

6.1.1: Growth Opportunities for Global Biocatalysis & Biocatalysts Market by Catalyst Type

6.1.2: Growth Opportunities for Global Biocatalysis & Biocatalysts Market by End Use Industry

6.1.3: Growth Opportunities for Global Biocatalysis & Biocatalysts Market by Region

6.2: Emerging Trends in Global Biocatalysis & Biocatalysts Market

6.3: Strategic Analysis

6.3.1: New Product Development

6.3.2: Capacity Expansion of Global Biocatalysis & Biocatalysts Market

6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market

6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

7.1: DowDupont

7.2: Royal DSM N.V.

7.3: Codexis Inc.

7.4: BASF SE

7.5: AB Enzymes Gmbh

7.6: Amano Enzymes

7.7: Novozymes A/S

7.8: Chr. Hansen

7.9: Dyadic International Inc.

7.10: The Soufflet Group

For more information about this report visit https://www.researchandmarkets.com/r/1p8tcx

These press releases may also interest you

at 12:01
Innovaccer Inc., a leading healthcare technology company, announced today that it has closed a new round of growth funding at a $1.3 billion post-money valuation, led by Tiger Global Management. Existing investors Steadview Capital, Dragoneer, B...

at 12:00
Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generation Sofwave system. Aesthetic practices adding Sofwave to...

at 12:00
Rare diseases approximately affect 300 million people globally. In the US, a rare disease affects fewer than 200,000 people (Orphan Drug Act), whereas, in the European Union, a rare disease affects fewer than 1 in 2,000 people. However, rare diseases...

at 12:00
The "Medical Tourism Global Potential 2021: Volume 1 - Background and Figures" report has been added to ResearchAndMarkets.com's offering. This report will help you to understand the competition in terms of which countries have the highest number of...

at 12:00
Titan HST, a leading provider of next-gen emergency response systems, announced the use of its emergency mass communication system at Vanguard University in Costa Mesa to help safeguard students and faculty in the event of on-campus emergencies,...

at 12:00
Dr. David Mahjoubi, a leading board-certified Anesthesiologist and founder of the Ketamine Healing Clinic of Los Angeles provides IV ketamine treatment therapy to treat many health issues such as Depression (including treatment-resistant), PTSD,...

News published on 19 january 2021 at 06:15 and distributed by: